Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dodick

Showing results (481-490 of 620) with videos related to

Pageof 62
Sort By:
Headache|September 5, 2013
Identifying the factors underlying discontinuation of triptansRebecca E Wells, Shira Y Markowitz, Eric P Baron, et al.
Neurology|June 10, 2016
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time pointsMarcelo E Bigal, David W Dodick, Abouch V Krymchantowski, et al.
Brain : a Journal of Neurology|March 24, 2022
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraineMoe Watanabe, Caroline M Kopruszinski, Aubin Moutal, et al.
Annals of Neurology|December 10, 1999
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating diseaseB G Weinshenker, P C O'Brien, T M Petterson, et al.
Headache|February 17, 2021
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) studyAriane K Kawata, Neel Shah, Jiat-Ling Poon, et al.
Headache|October 4, 2025
Navigating the patient journey in migraine prevention: An American Migraine Foundation position paperLawrence C Newman, Christine Lay, Richard B Lipton, et al.
Headache|December 28, 2021
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine DiaryRichard B Lipton, Pranav Gandhi, Jonathan Stokes, et al.
European Journal of Neurology|January 5, 2021
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trialMessoud Ashina, Peter J Goadsby, Uwe Reuter, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 1, 2022
Sleep restriction alters cortical inhibition in migraine: A transcranial magnetic stimulation studyMartin Syvertsen Mykland, Martin Uglem, Jan Petter Neverdahl, et al.
Headache|October 27, 2018
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine TrackerDavid W Dodick, Stewart J Tepper, Richard B Lipton, et al.
Pageof 62

Showing results (481-490 of 620) with videos related to

Sort By:
Pageof 62
Headache|September 5, 2013
Identifying the factors underlying discontinuation of triptansRebecca E Wells, Shira Y Markowitz, Eric P Baron, et al.
Neurology|June 10, 2016
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time pointsMarcelo E Bigal, David W Dodick, Abouch V Krymchantowski, et al.
Brain : a Journal of Neurology|March 24, 2022
Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraineMoe Watanabe, Caroline M Kopruszinski, Aubin Moutal, et al.
Annals of Neurology|December 10, 1999
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating diseaseB G Weinshenker, P C O'Brien, T M Petterson, et al.
Headache|February 17, 2021
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) studyAriane K Kawata, Neel Shah, Jiat-Ling Poon, et al.
Headache|October 4, 2025
Navigating the patient journey in migraine prevention: An American Migraine Foundation position paperLawrence C Newman, Christine Lay, Richard B Lipton, et al.
Headache|December 28, 2021
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine DiaryRichard B Lipton, Pranav Gandhi, Jonathan Stokes, et al.
European Journal of Neurology|January 5, 2021
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trialMessoud Ashina, Peter J Goadsby, Uwe Reuter, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 1, 2022
Sleep restriction alters cortical inhibition in migraine: A transcranial magnetic stimulation studyMartin Syvertsen Mykland, Martin Uglem, Jan Petter Neverdahl, et al.
Headache|October 27, 2018
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine TrackerDavid W Dodick, Stewart J Tepper, Richard B Lipton, et al.
Pageof 62